The 2015 Revised Chompret criteria, consisting of items on family history, multiple or rare cancers, and breast cancer before the age of 31 years, are widely used to raise clinical suspicion and justify TP53 constitutional testing (Chompret et al. 2001). Here, TP53 is linked to cancer.